Registry of Acute Stroke Under Novel Oral Anticoagulants - Prime

CompletedOBSERVATIONAL
Enrollment

3,832

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

January 31, 2021

Study Completion Date

June 30, 2022

Conditions
Ischemic StrokeIntracerebral HemorrhageOral AnticoagulationCardiovascular DiseasesVascular Diseases
Interventions
OTHER

not applicable (observational study)

Observational study without study related intervention.

Trial Locations (1)

69120

University Hospital Heidelberg, Heidelberg

All Listed Sponsors
collaborator

Bayer Healthcare Pharmaceuticals, Inc./Bayer Schering Pharma

INDUSTRY

collaborator

Boehringer Ingelheim

INDUSTRY

collaborator

Bristol-Myers Squibb

INDUSTRY

collaborator

Daiichi Sankyo

INDUSTRY

collaborator

University of Wuerzburg

OTHER

lead

University Hospital Heidelberg

OTHER